Abstract: A milk protein beverage, including: milk protein; one or more polyphenol-containing agent; and one or more calcium-binding chelator compound, wherein the milk protein beverage has a viscosity difference of less than 150 cP across a temperature range of 2 to 30° C. A method of producing the milk protein beverage, the method including: forming a first liquid including water, one or more polyphenol-containing agent, and one or more calcium-binding chelator compound; forming a second liquid including a milk concentrate; combining the first liquid and the second liquid to form a third liquid; homogenizing the third liquid; and thermally processing the third liquid to form the milk protein beverage, the thermal processing including a temperature of 105 to 140° C. A milk protein beverage, including: milk protein; and one or more calcium-binding chelator compound, the milk protein beverage having a viscosity difference of less than 150 cP across the temperature range.

Abstract: Compositions comprising a mixture of an antimicrobial cationic polypeptide and a second pharmaceutically-acceptable polymer are disclosed, as well as methods and uses thereof for the treatment and prevention of infections that occur when our natural barriers of defense are broken.

Abstract: Compositions comprising a mixture of an antimicrobial cationic polypeptide and a second pharmaceutically-acceptable polymer are disclosed, as well as methods and uses thereof for the treatment and prevention of infections that occur when our natural barriers of defense are broken.

Abstract: Compositions comprising a mixture of an antimicrobial cationic polypeptide and a second pharmaceutically-acceptable polymer are disclosed, as well as methods and uses thereof for the treatment and prevention of infections that occur when our natural barriers of defense are broken.

Abstract: Compositions comprising a mixture of an antimicrobial cationic polypeptide and a second pharmaceutically-acceptable polymer are disclosed, as well as methods and uses thereof for the treatment and prevention of infections that occur when our natural barriers of defense are broken.

Abstract: Improved synthetic copolypeptide antimicrobials contain cationic amino acid residues and may be based on a blocky sequence. These antimicrobials show low mammalian toxicity and may undergo directed self-assembly. The inventive synthetic copolypeptides are useful in treatment of wounds and other infections.

Abstract: A method for determining an amount of electricity to purchase includes determining electrical power consumption characteristics of an electrical load at an end user of the electricity. A preference of the end user for an output of the electrical load is ascertained. The output varies with a rate of electrical power consumption by the load. A mathematical model is created of an amount of electrical power to be consumed by the load as a function of time and of monetary cost of the electricity. The model is dependent upon the electrical power consumption characteristics of the electrical load and the preference of the end user for an output of the electrical load. An amount of electricity is purchased based on the mathematical model of an amount of electrical power to be consumed by the load, and based on the monetary cost of the electricity.

Abstract: Improved synthetic copolypeptide antimicrobials contain cationic amino acid residues and may be based on a blocky sequence. These antimicrobials show low mammalian toxicity and may undergo directed self-assembly. The inventive synthetic copolypeptides are useful in treatment of wounds and other infections.

Abstract: Compositions comprising a mixture of an antimicrobial cationic polypeptide and a second pharmaceutically-acceptable polymer are disclosed, as well as methods and uses thereof for the treatment and prevention of infections that occur when our natural barriers of defense are broken.

Abstract: A method distinguishes electrical signals corresponding to an activation or deactivation of a single electrical power consuming device from an electrical signal that supplies electricity to multiple electrical power consuming devices has been developed. The method includes generating signatures corresponding to activation and deactivation of a plurality of electrical devices from a transformation of an electrical power signal using sparse deconvolution to cluster and then identify the activation and deactivation of one of the plurality of electrical devices.

Abstract: Compositions comprising a mixture of an antimicrobial cationic polypeptide and a second pharmaceutically-acceptable polymer are disclosed, as well as methods and uses thereof for the treatment and prevention of infections that occur when our natural barriers of defense are broken.

Abstract: A method for determining an amount of electricity to purchase includes determining electrical power consumption characteristics of an electrical load at an end user of the electricity. A preference of the end user for an output of the electrical load is ascertained. The output varies with a rate of electrical power consumption by the load. A mathematical model is created of an amount of electrical power to be consumed by the load as a function of time and of monetary cost of the electricity. The model is dependent upon the electrical power consumption characteristics of the electrical load and the preference of the end user for an output of the electrical load. An amount of electricity is purchased based on the mathematical model of an amount of electrical power to be consumed by the load, and based on the monetary cost of the electricity.

Abstract: Improved synthetic copolypeptide antimicrobials contain cationic amino acid residues and may be based on a blocky sequence. These antimicrobials show low mammalian toxicity and may undergo directed self-assembly. The inventive synthetic copolypeptides are useful in treatment of wounds and other infections.

Abstract: Improved synthetic copolypeptide antimicrobials contain cationic amino acid residues and may be based on a blocky sequence. These antimicrobials show low mammalian toxicity and may undergo directed self-assembly. The inventive synthetic copolypeptides are useful in treatment of wounds and other infections.

Abstract: Compositions comprising a mixture of an antimicrobial cationic polypeptide and a second pharmaceutically-acceptable polymer are disclosed, as well as methods and uses thereof for the treatment and prevention of infections that occur when our natural barriers of defense are broken.

Abstract: A method for a personal emergency response system includes receiving output signals of a nonintrusive load monitoring (NILM)system coupled to an electrical supply of an person's residence, the output signals indicating switching events of appliances connected to the electrical supply. A computer processor is then used to process the output signals in accordance with a machine learning algorithm to identify appliance activation routines. Rules are defined based on the identified appliance activation routines, and the computer processor is used to monitor the output signals and apply the rules to the output signals to identify appliance switching conditions that violate the rules.

Abstract: A method of detecting movement includes using a radar sensor to monitor a space, and receiving an output signal from the radar sensor. A Fourier transform is performed on the output signal to produce a frequency domain signal spectrum. The frequency domain signal spectrum is transformed into an acoustic domain signal. It is decided whether the output signal is indicative of movement of a predetermined object or a non-human animal dependent upon at least one feature of the acoustic domain signal and at least one spectral feature of the signal spectrum.

Abstract: Improved synthetic copolypeptide antimicrobials contain cationic amino acid residues and may be based on a blocky sequence. These antimicrobials show low mammalian toxicity and may undergo directed self-assembly. The inventive synthetic copolypeptides are useful in treatment of wounds and other infections.

Abstract: A method distinguishes electrical signals corresponding to an activation or deactivation of a single electrical power consuming device from an electrical signal that supplies electricity to multiple electrical power consuming devices has been developed. The method includes generating signatures corresponding to activation and deactivation of a plurality of electrical devices from a transformation of an electrical power signal using sparse deconvolution to cluster and then identify the activation and deactivation of one of the plurality of electrical devices.

Abstract: A method of detecting movement includes using a radar sensor to monitor a space, and receiving an output signal from the radar sensor. A Fourier transform is performed on the output signal to produce a frequency domain signal spectrum. The frequency domain signal spectrum is transformed into an acoustic domain signal. It is decided whether the output signal is indicative of movement of a predetermined object or a non-human animal dependent upon at least one feature of the acoustic domain signal and at least one spectral feature of the signal spectrum.